Spain-based Fundacion MEDINA, the Drugs for Neglected diseases initiated (DNDi) and Institut Pasteur Korea have bee...
Bio Health Worldwide Online, taking place from 19th to 30th of October 2020, is designed to overcome the ...
Samsung Biologics and Kanaph Therapeutics have entered into a strategic partnership to develop KNP-301, a bi-specific Fc...
Macrogen has established the first "Smart Mobile Lab" in Korea and has supplied it to Indonesia as w...
Celltrion Group has announced that the Korean Ministry of Food and Drug Safety (MFDS) has approved the company’s I...
South Korean firm Samsung Biologics and British multinational pharmaceutical company AstraZeneca have announced a long-t...
South Korea based Medit, a global provider of 3D measurement solutions for dental clinics and labs, including intra...
Atomwise, the leader in using artificial intelligence (AI) for small molecule drug discovery based in the US, has announ...
Samsung Biologics has entered into a service agreement with Panolos Bioscience to develop PB101, an Fc-fusion protein in...
PharmaJet®, the maker of innovative, needle-free injection technology based in the US, has announced that its Strati...
Excelra, a global data science and data analytics company headquartered in India, has announced its collaboration with S...
SK Biopharmaceuticals, Co., Ltd., has announced plans to initiate a Phase 3 clinical trial for cenobamate in A...
Global Strategic Institute at Korea Advanced Institute of Science and Technology (KAIST) launched innovative f...
Seegene, Inc. has introduced a single tube real-time RT-PCR assay, Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay, which ...
Researchers from Gwangju Institute of Science and Technology in Korea have developed a simple and low-cost diagnostic pl...
Korea Health Industry Development Institute (KHIDI), a government-funded institution that provides systematic and profes...
Seoul Viosys, a leading compound semiconductor solution provider in South Korea, announced that it has developed an opti...
Korea's LSK Global PS, a leading CRO to run Sinovac Phase III COVID-19 vaccine trial in Bangladesh. The company would m...
